The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares



Results

Search articles by EPIC code
NEWSFLOW

SkinBioTherapeutics – positive study results suggest this could be a six bagger from here!

2021-06-03 10:12:50

SkinBioTherapeutics (SBTX) has announced the results of the AxisBiotix-PsT consumer study of patients suffering from psoriasis and it says that it will now be seeking regulatory approval for the product as a food supplement in parallel in the UK, US and Europe… targeting a commercial launch of theAxisBiotix-Ps™ product in Q4 2021”.  Do the maths! This is going to be massive.

ARTICLE NEWSFLOW

SkinBioTherapeutics – new research programme adds to the vast potential but its looming Winclove results which are the key

2021-05-08 18:40:50

Noting that “there is now an extensive growing body of research demonstrating direct links between the microbiome and the immune system, and consequently skin health”, SkinBioTherapeutics (SBTX) announced, a couple of weeks ago, initiation of a research programme with the University of Manchester. This is good news but not the elephant in the room!

ARTICLE NEWSFLOW

SkinBioTherapeutics – new research programme - we are already 250% up but far more to come

2021-04-09 09:07:58

Noting that “there is now an extensive growing body of research demonstrating direct links between the microbiome and the immune system, and consequently skin health”, SkinBioTherapeutics (SBTX) has announced initiation of a research programme with the University of Manchester.

ARTICLE

SkinBioTherapeutics interims – apologies for delayed update and an upgrade but I had to ponder

2021-03-19 10:27:14

Notwithstanding the lock-in shenanigans with Optibiotix (OPTI) discussed HERE, I am more bullish than ever. The results from Skinbiotherapeutics (SBTX) for the six months to 31 December 2020 came out on Monday. I apologise for the delayed update but I needed to ponder a while. What we read a few days ago was just excellent. Hence this upgrade.

ARTICLE

SkinBioTherapeutics – AxisBiotix study enrolment commences, set for a breakthrough year?

2021-01-16 14:04:35

Making SkinBioTherapeutics (SBTX) one of our three tips of the year 2021, we noted we considered it likely to make 2021 a breakthrough year, including with a planned first quarter human study for AxisBiotix™ targeting psoriasis and then, subject to a positive readout, commencing commercialisation. Already we now have an Enrolment for AxisBiotix-PsT study commences” announcement and the shares are already massively higher than our 15.5p tip price at 29p. But you'd be mad to sell.

ARTICLE

Rumour and counter rumour and Skinbiotherapeutics

2021-01-11 16:01:55

Shares in this company, where I am a loyal shareholder, raced ahead to 33p on Friday.  The excitement was driven largely by a false rumour and in part, methinks, on a rumour that is true. This morning I had it confirmed that the false rumour was, er, false.

ARTICLE

Skinbiotherapeutics placing at 16p – why am I not impressed? But through gritted teeth a buyer

2020-10-16 11:32:17

Skinbiotherapeutics (SBTX) boss Stuart Ashman until today held zero shares in the company. And he told us all that it had enough cash to last it until the end of next year at least.  And so now there is a £4 million placing and £500,000 open offer at 16p.  Mr Ashman can you see why I might be annoyed?

ARTICLE NEWSFLOW

SkinBiotherapeutics: more good news, increased targets upgrade of stance

2020-08-02 12:53:54

Very excited shareholder Tom Winnifrith writes: On 26 May 2020, Steve and I tipped SkinBiotherapeutics (SBTX) at a 17.75p offer and at up to 20p with a target price of 30p. News last week suggests that, notwithstanding this company wasting a few grand a month employing the biggest knobhead in Christendom to do its PR, we were more than a tad conservative and the shares now trade at 22p-23.5p and are still dirt cheap.

ARTICLE

SkinBioTherapeutics – “Business Update”, remains a buy...

2020-07-10 12:54:39

SkinBioTherapeutics (SBTX) has updated that it is “very pleased with the progress that the company has been able to make during these most exceptional times”, particularly including “several months ahead of schedule, Winclove has now been able to successfully combine and formulate the blend as a probiotic food supplement, to be known as AxisBiotix ™Ps”...

ARTICLE

Skinbiotherapeutics, the most idiotic of PR men and an email exchange

2020-07-08 09:44:11

There are only two financial journalists who write regularly about Skinbiotherapeutics (SBTX): myself and Steve Moore. Coverage elsewhere is minimal to zero yet for some reason the company wastes the cash of loyal shareholders such as myself, on Instinctif, a financial PR firm.  Yesterday at 4.16PM on trading statement day Mr Phillip Marriage of Instinctif dropped me an email. I suspect he wishes he had not.  Our full exchange follows.

ARTICLE NEWSFLOW NEWSFLOW NEWSFLOW

Video: SkinBioTherapeutics presents and takes questions at the UK Investor Show City forum on December 3

2018-12-07 01:37:36

The next City Forum is on January 21 with Adam Reynolds as the guest speaker being quizzed by the Sith Lord Zak Mir. I bet Adam's quaking about that grilling. Three companies will also present and take questions as will Adam. Put the date in your diary. From this week's seminar here is Skinbiotherapeutics (SBTX) presenting and taking questions.

ARTICLE NEWSFLOW

ShareProphets readers tips for 2018 competition - end October update

2018-11-05 15:30:47

Having asked for readers tips for 2018 for the amazing prize of a meal with Tom Winnifrith (or the chance to fob it off on someone you don't like) HERE, the following is a monthly update on performance (to be eligible needed to have selected, on a per username basis, a buy & sell pick from the LSE or AIM Casino and the stocks not to have been suspended at the commencement of 2018)...

ARTICLE

ShareProphets readers tips for 2018 competition - end September update

2018-10-02 08:12:11

Having asked for readers tips for 2018 for the amazing prize of a meal with Tom Winnifrith (or the chance to fob it off on someone you don't like) HERE, the following is a monthly update on performance (to be eligible needed to have selected, on a per username basis, a buy & sell pick from the LSE or AIM Casino and the stocks not to have been suspended at the commencement of 2018)...

ARTICLE NEWSFLOW

ShareProphets readers tips for 2018 competition - August bank holiday update

2018-08-26 13:08:19

Having asked for readers tips for 2018 for the amazing prize of a meal with Tom Winnifrith (or the chance to fob it off on someone you don't like) HERE, the following is a monthly update on performance (to be eligible needed to have selected, on a per username basis, a buy & sell pick from the LSE or AIM Casino and the stocks not to have been suspended at the commencement of 2018)...

ARTICLE NEWSFLOW

ShareProphets readers tips for 2018 competition - end July update

2018-08-02 10:36:07

Having asked for readers tips for 2018 for the amazing prize of a meal with Tom Winnifrith (or the chance to fob it off on someone you don't like) HERE, the following is a monthly update on performance (to be eligible needed to have selected, on a per username basis, a buy & sell pick from the LSE or AIM Casino and the stocks not to have been suspended at the commencement of 2018)...

ARTICLE NEWSFLOW NEWSFLOW NEWSFLOW

SkinBioTherapeutics – successful AIM admission for a UK Investor Show ‘Golden Share’

2017-04-05 08:55:39

Tom Winnifrith’s ‘Golden Share’ (all proceeds to Woodlarks) from Saturday’s 2017 UK Investor Show has today listed on AIM – and it’s good news…

ARTICLE



About ShareProphets

Contact Us

Advertise With Us

Send Us A Tip

Donate


Terms of Service

Privacy Policy

Cookie Policy


Forgot My Password

Forgot My Username

Resend Account Validation Token

Site by Everywhen